News

Video

The new standard for medical malpractice: What makes a clinical guideline legally defensible?

Author(s):

Fact checked by:

Daniel Aaron, M.D., J.D., an associate professor of law at the University of Utah, explains what makes a guideline “legitimate” in the eyes of the law, and what physicians and health system leaders should watch for.

Under the American Law Institute’s new malpractice framework, courts are encouraged to consider clinical guidelines — but not all guidelines are created equal.

In an interview with Medical Economics, Daniel Aaron, M.D., J.D., explains what makes a guideline “legitimate” in the eyes of the law, and what physicians and health system leaders should watch for.

“Most guidelines that physicians organizations issue are going to likely be legitimate,” Aaron said. “Physicians should do what they generally do, which is defer to their organization's guidelines.”

The restatement specifically warns against giving weight to guidelines issued by non-physician or non-expert groups. “Courts will ensure that guidelines are legitimate and evidence based and reputable,” Aaron said. “They’re not going to reflexively follow unsupported guidelines.”

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Videos
The new standard for medical malpractice: A conversation with Daniel G. Aaron, M.D., J.D.
The new standard for medical malpractice: What to watch for
The new standard for medical malpractice: A step toward ending defensive medicine?
The new standard for medical malpractice: Can doctors be liable for doing what everyone else does?
The new standard for medical malpractice: What it means for day-to-day practice
The new standard for medical malpractice: What changed?
The new standard for medical malpractice: Why the law just changed
ACP policy update 2025: A conversation with Brian E. Outland, PhD
ACP policy update 2025 interview